10.74美元0.44(3.94%)
2021/02/25更新
績效 / 1月11.46%
3月1.13%
1年
晨星評等-
淨值走勢
持股明細 / 風險評估
- 1.美國57.72%
- 2.新興亞洲14.91%
- 3.已開發亞洲6.19%
- 4.日本5.54%
- 5.歐洲不包含歐元區2.69%
- 1.健康護理84.40%
- 2.科技2.38%
- 3.周期性消費1.78%
- 1.Halozyme Therapeutics Inc5.46%
- 2.CVS Health Corp3.48%
- 3.Align Technology Inc3.46%
- 4.Natera Inc3.39%
- 5.Sarepta Therapeutics Inc3.20%
- 1.美國57.72%
- 2.新興亞洲14.91%
- 3.已開發亞洲6.19%
- 4.日本5.54%
- 5.歐洲不包含歐元區2.69%
- 1.Halozyme Therapeutics Inc5.46%
- 2.CVS Health Corp3.48%
- 3.Align Technology Inc3.46%
- 4.Natera Inc3.39%
- 5.Sarepta Therapeutics Inc3.20%
- 1.健康護理84.40%
- 2.科技2.38%
- 3.周期性消費1.78%